Abstract
Summary
A Second Medical Opinion Service refers to a healthcare offering where individuals seek an additional evaluation or consultation from another medical professional or specialist to validate or supplement the diagnosis or treatment plan provided by their primary healthcare provider. This service is particularly valuable in complex medical cases, serious illnesses, or when individuals desire more information and confidence in their healthcare decisions.
The global Second Medical Opinion Service market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Second Medical Opinion Service Industry Forecast” looks at past sales and reviews total world Second Medical Opinion Service sales in 2023, providing a comprehensive analysis by region and market sector of projected Second Medical Opinion Service sales for 2024 through 2030. With Second Medical Opinion Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Second Medical Opinion Service industry.
This Insight Report provides a comprehensive analysis of the global Second Medical Opinion Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Second Medical Opinion Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Second Medical Opinion Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Second Medical Opinion Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Second Medical Opinion Service.
The Second Medical Opinion Service is currently experiencing rapid growth, with an expanding market size and substantial increases in sales. As people become more health-conscious and seek diverse medical solutions, the service plays a pivotal role in providing comprehensive and specialized medical advice. Beyond offering reliable second opinions on disease diagnosis and treatment, it actively contributes to areas such as surgical choices and treatment plan development. Looking ahead, with advancing technologies and a growing trend of patient empowerment in medical decision-making, the Second Medical Opinion Service is poised for continued robust development, providing patients with more options and enhanced support for medical decision-making.
This report presents a comprehensive overview, market shares, and growth opportunities of Second Medical Opinion Service market by product type, application, key players and key regions and countries.
Segmentation by type
Hospitals
Medical Services Company
Insurance Company
Segmentation by application
Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Ocular Disorders
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
HCA Healthcare
AXA Global Healthcare
Royal London
Helsana
Cleveland Clinic
Amradnet
Best Doctors
Toranomon Hospital
Keio University Hospital
Johns Hopkins Medicine
Penn Medicine
HCG Onoclogy
GrandOpinion
London Pain Clinic
Medisense
Medical Opinion Asia
Medicaim
C3Medical
The global Second Medical Opinion Service market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Second Medical Opinion Service Industry Forecast” looks at past sales and reviews total world Second Medical Opinion Service sales in 2023, providing a comprehensive analysis by region and market sector of projected Second Medical Opinion Service sales for 2024 through 2030. With Second Medical Opinion Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Second Medical Opinion Service industry.
This Insight Report provides a comprehensive analysis of the global Second Medical Opinion Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Second Medical Opinion Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Second Medical Opinion Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Second Medical Opinion Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Second Medical Opinion Service.
The Second Medical Opinion Service is currently experiencing rapid growth, with an expanding market size and substantial increases in sales. As people become more health-conscious and seek diverse medical solutions, the service plays a pivotal role in providing comprehensive and specialized medical advice. Beyond offering reliable second opinions on disease diagnosis and treatment, it actively contributes to areas such as surgical choices and treatment plan development. Looking ahead, with advancing technologies and a growing trend of patient empowerment in medical decision-making, the Second Medical Opinion Service is poised for continued robust development, providing patients with more options and enhanced support for medical decision-making.
This report presents a comprehensive overview, market shares, and growth opportunities of Second Medical Opinion Service market by product type, application, key players and key regions and countries.
Segmentation by type
Hospitals
Medical Services Company
Insurance Company
Segmentation by application
Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Ocular Disorders
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
HCA Healthcare
AXA Global Healthcare
Royal London
Helsana
Cleveland Clinic
Amradnet
Best Doctors
Toranomon Hospital
Keio University Hospital
Johns Hopkins Medicine
Penn Medicine
HCG Onoclogy
GrandOpinion
London Pain Clinic
Medisense
Medical Opinion Asia
Medicaim
C3Medical
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Second Medical Opinion Service Market Size 2019-2030
2.1.2 Second Medical Opinion Service Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Second Medical Opinion Service Segment by Type
2.2.1 Hospitals
2.2.2 Medical Services Company
2.2.3 Insurance Company
2.3 Second Medical Opinion Service Market Size by Type
2.3.1 Second Medical Opinion Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Second Medical Opinion Service Market Size Market Share by Type (2019-2024)
2.4 Second Medical Opinion Service Segment by Application
2.4.1 Cancer
2.4.2 Diabetes
2.4.3 Cardiac Disorders
2.4.4 Neurological Disorders
2.4.5 Ocular Disorders
2.4.6 Others
2.5 Second Medical Opinion Service Market Size by Application
2.5.1 Second Medical Opinion Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Second Medical Opinion Service Market Size Market Share by Application (2019-2024)
3 Second Medical Opinion Service Market Size by Player
3.1 Second Medical Opinion Service Market Size Market Share by Players
3.1.1 Global Second Medical Opinion Service Revenue by Players (2019-2024)
3.1.2 Global Second Medical Opinion Service Revenue Market Share by Players (2019-2024)
3.2 Global Second Medical Opinion Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Second Medical Opinion Service by Regions
4.1 Second Medical Opinion Service Market Size by Regions (2019-2024)
4.2 Americas Second Medical Opinion Service Market Size Growth (2019-2024)
4.3 APAC Second Medical Opinion Service Market Size Growth (2019-2024)
4.4 Europe Second Medical Opinion Service Market Size Growth (2019-2024)
4.5 Middle East & Africa Second Medical Opinion Service Market Size Growth (2019-2024)
5 Americas
5.1 Americas Second Medical Opinion Service Market Size by Country (2019-2024)
5.2 Americas Second Medical Opinion Service Market Size by Type (2019-2024)
5.3 Americas Second Medical Opinion Service Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Second Medical Opinion Service Market Size by Region (2019-2024)
6.2 APAC Second Medical Opinion Service Market Size by Type (2019-2024)
6.3 APAC Second Medical Opinion Service Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Second Medical Opinion Service by Country (2019-2024)
7.2 Europe Second Medical Opinion Service Market Size by Type (2019-2024)
7.3 Europe Second Medical Opinion Service Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Second Medical Opinion Service by Region (2019-2024)
8.2 Middle East & Africa Second Medical Opinion Service Market Size by Type (2019-2024)
8.3 Middle East & Africa Second Medical Opinion Service Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Second Medical Opinion Service Market Forecast
10.1 Global Second Medical Opinion Service Forecast by Regions (2025-2030)
10.1.1 Global Second Medical Opinion Service Forecast by Regions (2025-2030)
10.1.2 Americas Second Medical Opinion Service Forecast
10.1.3 APAC Second Medical Opinion Service Forecast
10.1.4 Europe Second Medical Opinion Service Forecast
10.1.5 Middle East & Africa Second Medical Opinion Service Forecast
10.2 Americas Second Medical Opinion Service Forecast by Country (2025-2030)
10.2.1 United States Second Medical Opinion Service Market Forecast
10.2.2 Canada Second Medical Opinion Service Market Forecast
10.2.3 Mexico Second Medical Opinion Service Market Forecast
10.2.4 Brazil Second Medical Opinion Service Market Forecast
10.3 APAC Second Medical Opinion Service Forecast by Region (2025-2030)
10.3.1 China Second Medical Opinion Service Market Forecast
10.3.2 Japan Second Medical Opinion Service Market Forecast
10.3.3 Korea Second Medical Opinion Service Market Forecast
10.3.4 Southeast Asia Second Medical Opinion Service Market Forecast
10.3.5 India Second Medical Opinion Service Market Forecast
10.3.6 Australia Second Medical Opinion Service Market Forecast
10.4 Europe Second Medical Opinion Service Forecast by Country (2025-2030)
10.4.1 Germany Second Medical Opinion Service Market Forecast
10.4.2 France Second Medical Opinion Service Market Forecast
10.4.3 UK Second Medical Opinion Service Market Forecast
10.4.4 Italy Second Medical Opinion Service Market Forecast
10.4.5 Russia Second Medical Opinion Service Market Forecast
10.5 Middle East & Africa Second Medical Opinion Service Forecast by Region (2025-2030)
10.5.1 Egypt Second Medical Opinion Service Market Forecast
10.5.2 South Africa Second Medical Opinion Service Market Forecast
10.5.3 Israel Second Medical Opinion Service Market Forecast
10.5.4 Turkey Second Medical Opinion Service Market Forecast
10.5.5 GCC Countries Second Medical Opinion Service Market Forecast
10.6 Global Second Medical Opinion Service Forecast by Type (2025-2030)
10.7 Global Second Medical Opinion Service Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 HCA Healthcare
11.1.1 HCA Healthcare Company Information
11.1.2 HCA Healthcare Second Medical Opinion Service Product Offered
11.1.3 HCA Healthcare Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 HCA Healthcare Main Business Overview
11.1.5 HCA Healthcare Latest Developments
11.2 AXA Global Healthcare
11.2.1 AXA Global Healthcare Company Information
11.2.2 AXA Global Healthcare Second Medical Opinion Service Product Offered
11.2.3 AXA Global Healthcare Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AXA Global Healthcare Main Business Overview
11.2.5 AXA Global Healthcare Latest Developments
11.3 Royal London
11.3.1 Royal London Company Information
11.3.2 Royal London Second Medical Opinion Service Product Offered
11.3.3 Royal London Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Royal London Main Business Overview
11.3.5 Royal London Latest Developments
11.4 Helsana
11.4.1 Helsana Company Information
11.4.2 Helsana Second Medical Opinion Service Product Offered
11.4.3 Helsana Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Helsana Main Business Overview
11.4.5 Helsana Latest Developments
11.5 Cleveland Clinic
11.5.1 Cleveland Clinic Company Information
11.5.2 Cleveland Clinic Second Medical Opinion Service Product Offered
11.5.3 Cleveland Clinic Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cleveland Clinic Main Business Overview
11.5.5 Cleveland Clinic Latest Developments
11.6 Amradnet
11.6.1 Amradnet Company Information
11.6.2 Amradnet Second Medical Opinion Service Product Offered
11.6.3 Amradnet Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amradnet Main Business Overview
11.6.5 Amradnet Latest Developments
11.7 Best Doctors
11.7.1 Best Doctors Company Information
11.7.2 Best Doctors Second Medical Opinion Service Product Offered
11.7.3 Best Doctors Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Best Doctors Main Business Overview
11.7.5 Best Doctors Latest Developments
11.8 Toranomon Hospital
11.8.1 Toranomon Hospital Company Information
11.8.2 Toranomon Hospital Second Medical Opinion Service Product Offered
11.8.3 Toranomon Hospital Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Toranomon Hospital Main Business Overview
11.8.5 Toranomon Hospital Latest Developments
11.9 Keio University Hospital
11.9.1 Keio University Hospital Company Information
11.9.2 Keio University Hospital Second Medical Opinion Service Product Offered
11.9.3 Keio University Hospital Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Keio University Hospital Main Business Overview
11.9.5 Keio University Hospital Latest Developments
11.10 Johns Hopkins Medicine
11.10.1 Johns Hopkins Medicine Company Information
11.10.2 Johns Hopkins Medicine Second Medical Opinion Service Product Offered
11.10.3 Johns Hopkins Medicine Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Johns Hopkins Medicine Main Business Overview
11.10.5 Johns Hopkins Medicine Latest Developments
11.11 Penn Medicine
11.11.1 Penn Medicine Company Information
11.11.2 Penn Medicine Second Medical Opinion Service Product Offered
11.11.3 Penn Medicine Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Penn Medicine Main Business Overview
11.11.5 Penn Medicine Latest Developments
11.12 HCG Onoclogy
11.12.1 HCG Onoclogy Company Information
11.12.2 HCG Onoclogy Second Medical Opinion Service Product Offered
11.12.3 HCG Onoclogy Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 HCG Onoclogy Main Business Overview
11.12.5 HCG Onoclogy Latest Developments
11.13 GrandOpinion
11.13.1 GrandOpinion Company Information
11.13.2 GrandOpinion Second Medical Opinion Service Product Offered
11.13.3 GrandOpinion Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 GrandOpinion Main Business Overview
11.13.5 GrandOpinion Latest Developments
11.14 London Pain Clinic
11.14.1 London Pain Clinic Company Information
11.14.2 London Pain Clinic Second Medical Opinion Service Product Offered
11.14.3 London Pain Clinic Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 London Pain Clinic Main Business Overview
11.14.5 London Pain Clinic Latest Developments
11.15 Medisense
11.15.1 Medisense Company Information
11.15.2 Medisense Second Medical Opinion Service Product Offered
11.15.3 Medisense Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Medisense Main Business Overview
11.15.5 Medisense Latest Developments
11.16 Medical Opinion Asia
11.16.1 Medical Opinion Asia Company Information
11.16.2 Medical Opinion Asia Second Medical Opinion Service Product Offered
11.16.3 Medical Opinion Asia Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Medical Opinion Asia Main Business Overview
11.16.5 Medical Opinion Asia Latest Developments
11.17 Medicaim
11.17.1 Medicaim Company Information
11.17.2 Medicaim Second Medical Opinion Service Product Offered
11.17.3 Medicaim Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Medicaim Main Business Overview
11.17.5 Medicaim Latest Developments
11.18 C3Medical
11.18.1 C3Medical Company Information
11.18.2 C3Medical Second Medical Opinion Service Product Offered
11.18.3 C3Medical Second Medical Opinion Service Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 C3Medical Main Business Overview
11.18.5 C3Medical Latest Developments
12 Research Findings and Conclusion